TORONTO – October 14, 2026 -- Patients treated with whole-gland TULSA were more than twice as likely to preserve both erectile function and pad-free continence at six months as those who had robotic radical prostatectomy (risk ratio 2.1; p=0.004), according to CAPTAIN trial data. Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) presented the results among five abstracts at the 15th Interventional MRI Symposium in Boston.

Berlin – September 16, 2026 -- Aignostics has opened early access to PathoSearch, a visual search engine that retrieves diagnosed reference pathology cases from a single screenshot of an H&E slide, targeting the rare and complex cases that make up as much as 20% of a pathologist's caseload.

San Francisco – September 07, 2026 -- Rainfall Health announced that Mayo Clinic in Jacksonville, Florida will deploy its AI-driven platform to manage care coordination and compliance under the Centers for Medicare & Medicaid Services' Transforming Episode Accountability Model (TEAM), a mandatory payment program that took effect January 1, 2026.

New York – September 07, 2026 -- Bayesian Health has secured a New Technology Add-on Payment (NTAP) from the Centers for Medicare and Medicaid Services, making it the first continuous sepsis monitoring technology to hold both FDA clearance and a dedicated Medicare reimbursement pathway.

The approval, issued under CMS's FY 2027 Inpatient Prospective Payment System Final Rule, takes effect October 1, 2026, and allows hospitals using Bayesian's FDA-cleared sepsis flagging device to bill Medicare an add-on payment of up to $61.84 per eligible inpatient case.